Abbott Laboratories EBITDA 2010-2025 | ABT

Abbott Laboratories annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Abbott Laboratories EBITDA for the quarter ending March 31, 2025 was $2.718B, a 4.82% increase year-over-year.
  • Abbott Laboratories EBITDA for the twelve months ending March 31, 2025 was $10.043B, a 3.31% increase year-over-year.
  • Abbott Laboratories 2024 annual EBITDA was $10.043B, a 3.31% increase from 2023.
  • Abbott Laboratories 2023 annual EBITDA was $9.721B, a 16.41% decline from 2022.
  • Abbott Laboratories 2022 annual EBITDA was $11.629B, a 2.79% decline from 2021.
Abbott Laboratories Annual EBITDA
(Millions of US $)
2024 $10,043
2023 $9,721
2022 $11,629
2021 $11,963
2020 $8,684
2019 $7,546
2018 $6,960
2017 $5,497
2016 $4,544
2015 $4,339
2014 $4,147
2013 $3,852
2012 $4,142
2011 $4,673
2010 $8,712
2009 $8,325
Abbott Laboratories Quarterly EBITDA
(Millions of US $)
2024-12-31 $2,718
2024-09-30 $2,660
2024-06-30 $2,474
2024-03-31 $2,191
2023-12-31 $2,593
2023-09-30 $2,471
2023-06-30 $2,342
2023-03-31 $2,315
2022-12-31 $2,111
2022-09-30 $2,585
2022-06-30 $3,198
2022-03-31 $3,735
2021-12-31 $3,261
2021-09-30 $3,393
2021-06-30 $2,266
2021-03-31 $3,043
2020-12-31 $3,298
2020-09-30 $2,303
2020-06-30 $1,497
2020-03-31 $1,586
2019-12-31 $2,145
2019-09-30 $1,952
2019-06-30 $1,957
2019-03-31 $1,492
2018-12-31 $1,928
2018-09-30 $1,808
2018-06-30 $1,732
2018-03-31 $1,492
2017-12-31 $1,566
2017-09-30 $1,543
2017-06-30 $1,464
2017-03-31 $924
2016-12-31 $1,273
2016-09-30 $1,237
2016-06-30 $1,163
2016-03-31 $871
2015-12-31 $1,181
2015-09-30 $1,096
2015-06-30 $1,081
2015-03-31 $981
2014-12-31 $1,224
2014-09-30 $1,083
2014-06-30 $1,077
2014-03-31 $763
2013-12-31 $844
2013-09-30 $909
2013-06-30 $1,063
2013-03-31 $1,036
2012-12-31 $564
2012-09-30 $1,070
2012-06-30 $1,256
2012-03-31 $1,252
2011-12-31 $2,731
2011-09-30 $1,433
2011-06-30 $2,585
2011-03-31 $2,047
2010-12-31 $2,540
2010-09-30 $1,858
2010-06-30 $2,281
2010-03-31 $2,033
2009-12-31 $2,411
2009-09-30 $2,180
2009-06-30 $2,209
2009-03-31 $1,525
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $229.641B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $152.191B 38.10
Stryker (SYK) United States $148.126B 30.97
EssilorLuxottica (ESLOY) France $127.448B 0.00
Medtronic (MDT) Ireland $110.055B 16.07
Lonza Group Ag (LZAGY) Switzerland $49.786B 0.00
Haleon (HLN) United Kingdom $48.281B 27.46
ResMed (RMD) United States $36.314B 27.27
GE HealthCare Technologies (GEHC) United States $33.934B 16.11
Agilent Technologies (A) United States $32.944B 21.76
Terumo (TRUMY) Japan $28.086B 0.00
Koninklijke Philips (PHG) Netherlands $23.536B 16.92
Insulet (PODD) United States $22.286B 87.48
Zimmer Biomet Holdings (ZBH) United States $19.433B 12.48
Baxter (BAX) United States $16.360B 12.22
Smith & Nephew SNATS (SNN) United Kingdom $12.456B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.030B 0.00
Bio-Rad Laboratories (BIO) United States $7.190B 24.31
Lantheus Holdings (LNTH) United States $5.502B 13.88
Prestige Consumer Healthcare (PBH) United States $4.350B 19.43
Perrigo (PRGO) Ireland $3.711B 9.40
ICU Medical (ICUI) United States $3.552B 26.20
Haemonetics (HAE) United States $3.528B 15.37
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.144B 26.13
QuidelOrtho (QDEL) United States $2.531B 17.41
GN Store Nord (GNNDY) Denmark $2.188B 18.12
LeMaitre Vascular (LMAT) United States $1.863B 41.65
AtriCure (ATRC) United States $1.575B 0.00
Neogen (NEOG) United States $1.411B 18.06
AdaptHealth (AHCO) United States $1.229B 12.48
Kestra Medical Technologies (KMTS) United States $1.211B 0.00
Green Thumb Industries (GTBIF) United States $1.152B 25.91
BioLife Solutions (BLFS) United States $1.135B 0.00
InMode (INMD) Israel $1.043B 9.55
Phibro Animal Health (PAHC) United States $0.992B 12.69
Evolus (EOLS) United States $0.643B 0.00
CeriBell (CBLL) United States $0.620B 0.00
Owens & Minor (OMI) United States $0.552B 4.58
Curaleaf Holdings (CURLF) Canada $0.545B 0.00
Valneva SE (VALN) France $0.539B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.539B 0.00
Tilray Brands (TLRY) Canada $0.462B 0.00
Surmodics (SRDX) United States $0.387B 0.00
Cresco Labs (CRLBF) United States $0.357B 0.00
SNDL (SNDL) Canada $0.347B 0.00
Capricor Therapeutics (CAPR) United States $0.325B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
VAREX IMAGING (VREX) United States $0.310B 11.39
Sanara MedTech (SMTI) United States $0.305B 0.00
Aurora Cannabis (ACB) Canada $0.284B 50.60
Canopy Growth (CGC) Canada $0.268B 0.00
Sanuwave Health (SNWV) United States $0.261B 0.00
Cerus (CERS) United States $0.258B 0.00
Viemed Healthcare (VMD) United States $0.257B 21.70
ZimVie (ZIMV) United States $0.248B 11.28
Verano Holdings (VRNOF) United States $0.248B 0.00
Quanterix (QTRX) United States $0.222B 0.00
Omeros (OMER) United States $0.221B 0.00
Biote (BTMD) United States $0.218B 6.14
OraSure Technologies (OSUR) United States $0.200B 0.00
High Tide (HITI) Canada $0.192B 0.00
Utah Medical Products (UTMD) United States $0.177B 14.29
Organigram Global (OGI) Canada $0.171B 0.00
Brainsway (BWAY) Israel $0.167B 51.94
TriSalus Life Sciences (TLSI) United States $0.165B 0.00
FitLife Brands (FTLF) United States $0.145B 17.82
Jin Medical (ZJYL) China $0.141B 0.00
Exagen (XGN) United States $0.123B 0.00
TerrAscend (TSNDF) Canada $0.107B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Agape ATP (ATPC) $0.083B 0.00
Fonar (FONR) United States $0.077B 10.76
Veru (VERU) United States $0.076B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
InterCure (INCR) Israel $0.069B 0.00
Zynex (ZYXI) United States $0.065B 0.00
United Health Products (UEEC) United States $0.061B 0.00
Cytosorbents (CTSO) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Apyx Medical (APYX) United States $0.042B 0.00
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 13.10
Safety Shot (SHOT) United States $0.037B 0.00
Rockwell Medical (RMTI) United States $0.036B 0.00
Nephros (NEPH) United States $0.022B 0.00
INLIF (INLF) $0.019B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00